Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-08

Clinical Trial Update: An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations [Phase 1]

View source ↗

Summary

A Phase 1 exploratory study evaluated the rectal safety of three tenofovir gel formulations for HIV prevention and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir gel (rectal formulations) (tenofovir gel)

Snippet

Sponsor: Ian McGowan | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED